Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2014-03-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mindfulness Based Cognitive Therapy for Youth With Anxiety at Risk for Bipolar Disorder
NCT02090595
Study of Mindfulness-Based Cognitive Therapy
NCT00943033
Mindfulness Intervention to Study the Neurobiology of Depression
NCT01905267
Mindfulness Based Compassionate Living in Recurrent Depression
NCT02059200
Mindfulness-Based Cognitive Therapy for Depressed IAPT Non-Responders
NCT05236959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Twelve children aged 10-17 with mood dysregulation and a bipolar parent will be in the study for 12 weeks. There will be two groups receiving intervention: one group recruited from the community and one group recruited from a known high-risk cohort.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MBCT-C Therapy
Mindfulness Based Cognitive Therapy for Children is a manualized psychotherapeutic intervention that combines mindfulness techniques with certain features of cognitive behavioral therapy. This particular protocol for youth includes weekly group sessions, regular home practice, and the core curriculum of formal mindfulness practices (e.g., body scan, sitting, movement, and walking meditations).
MBCT-C Therapy
Mindfulness Based Cognitive Therapy for Children is a manualized psychotherapeutic intervention that combines mindfulness techniques with certain features of cognitive behavioral therapy. This particular protocol for youth includes weekly group sessions, regular home practice, and the core curriculum of formal mindfulness practices (e.g., body scan, sitting, movement, and walking meditations).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MBCT-C Therapy
Mindfulness Based Cognitive Therapy for Children is a manualized psychotherapeutic intervention that combines mindfulness techniques with certain features of cognitive behavioral therapy. This particular protocol for youth includes weekly group sessions, regular home practice, and the core curriculum of formal mindfulness practices (e.g., body scan, sitting, movement, and walking meditations).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Ages 10 -17 years; inclusive at the time of consent
2. At least one biological parent with bipolar I disorder, confirmed with the SCID-P/L
3. CDRS-R score \> 28 or YMRS score \> 12 or ERC score \> 36 at screening and baseline since clinically significant elevation on any of these scales suggests mood dysregulation
4. Fluent in English
5. Provision of written informed consent/assent as previously described
6. Agrees to participate in at least 75% of sessions.
Exclusion Criteria
2. Any lifetime DSM-V diagnosis of bipolar disorder, schizophrenia or other psychotic disorder
3. Previous participation in a mindfulness-based treatment, including MBCT-C
4. A substance use disorder (except nicotine or caffeine) within the past 3 months
5. Judged clinically to be at risk from suicide as defined as having active suicidal ideation, intent or plan, or a serious suicide attempt within 30 days, or a baseline CDRS-R suicide score of \>3
6. Concurrent treatment with psychotropic medications that have been adjusted during the 30 days prior to screening or are anticipated during the course of study participation
7. Psychotherapy initiated within 2 month prior to screening or plan to initiate psychotherapy during study participation
8. Significant psychiatric symptoms that require hospitalization
9. Mood symptoms resulting from acute medical illness or acute intoxication or withdrawal from drugs or alcohol as determined by medical evaluation or rapid symptom resolution
10. Female patients who are either pregnant or lactating; All girls will have a urine pregnancy test prior to MR scans
11. Any contraindication to an MRI scan (e.g., metal clips, braces or claustrophobia)
12. Neurological disorders (e.g. epilepsy) or severe head trauma resulting in loss of consciousness for \> 10 minutes or any unstable medical illness.
10 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melissa Delbello
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melissa P DelBello, MD
Role: PRINCIPAL_INVESTIGATOR
University of Cincinnati
Sian Cotton, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cincinnati
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-0453
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.